H. Hogan
Vorstandsvorsitzender bei NABRIVA THERAPEUTICS PLC
Ursprung des Netzwerks ersten Grades von H. Hogan
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 12 | |
12
| Private Company | Biotechnology | 12 |
| Public Company | Biotechnology | 9 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von H. Hogan
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
Nabriva Therapeutics GmbH
 Nabriva Therapeutics GmbH Pharmaceuticals: MajorHealth Technology Nabriva Therapeutics GmbH is a clinical-stage biopharmaceutical company, which engages in the research and development of novel anti-infective agents to treat serious infections. It focuses on the pleuromutilin class of antibiotics. The company was founded by Rodger Novak in October 2005 and is headquartered in Vienna, Austria. | Pharmaceuticals: Major | Chief Executive Officer Chairman Director/Board Member Director/Board Member Director/Board Member Chief Tech/Sci/R&D Officer | |
Shire ViroPharma, Inc.
 Shire ViroPharma, Inc. Pharmaceuticals: MajorHealth Technology Shire ViroPharma, Inc. develops and manufactures drugs. It offers treatment for prophylaxis of hereditary angioedema, as well as capsules for the treatment of antibiotic associated pseudomembranous colitis caused by Clostridium difficile infection (CDI) and enterocolitis. The company was founded by Claude H. Nash and Mark A. McKinlay in September 1994 and is headquartered in Exton, PA. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Director of Finance/CFO Corporate Officer/Principal | |
| SPARK THERAPEUTICS, INC. | Biotechnology | Director of Finance/CFO Chief Tech/Sci/R&D Officer Human Resources Officer | |
| ATYR PHARMA, INC. | Pharmaceuticals: Major | Chief Executive Officer Consultant / Advisor Director of Finance/CFO | |
BIOCOM
 BIOCOM Miscellaneous Commercial ServicesCommercial Services BIOCOM provides scientific and technological services. The firm focuses that positively influence the growth of the life science industry, including capital formation, public policy, workforce development and scientific discovery and development. The company was founded in 1995 and is headquartered in San Diego, CA. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Director/Board Member | |
| San Diego State University | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
| SYNTHORX, INC. | Biotechnology | Director/Board Member Chief Executive Officer | |
DJO Global, Inc.
 DJO Global, Inc. Medical SpecialtiesHealth Technology DJO Global, Inc. engages in the development and distribution medical devices for musculoskeletal health, joint reconstruction, vascular health, and pain management. Its product include knee ligament bracing, custom bracing, post-op knee bracing, hip implants, shoulder implants, shoulder bracing, spine bracing, cervical collars, walking braces, and ankle bracing. The company was founded by Mark Nordquist and Ken Reed in 1978 and is headquartered in Lewisville, TX. | Medical Specialties | Director of Finance/CFO Director of Finance/CFO | |
Ernst & Young LLP
 Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Ernst & Young LLP engages in the provision of accounting, assurance, tax, transaction, and advisory services. It specializes in the actuarial, analytics and big data, cyber security, accounting compliance and reporting, center for board matters, international financial reporting standards, country tax advisory, global trade, tax accounting, and climate change and sustainability. The company was founded in 1989 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Comptroller/Controller/Auditor Comptroller/Controller/Auditor | |
| The Salk Institute for Biological Studies | College/University | Director/Board Member Director/Board Member | |
| CUBIST PHARMACEUTICALS INC | Pharmaceuticals: Major | Director/Board Member Sales & Marketing | |
| GRITSTONE BIO, INC. | Biotechnology | Director/Board Member Director/Board Member | |
| RECEPTOS INC | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| JANUX THERAPEUTICS, INC. | Biotechnology | Director/Board Member Chairman | |
Xenopharm, Inc.
 Xenopharm, Inc. Miscellaneous Commercial ServicesCommercial Services Xenopharm, Inc. develops drug sensing molecules. The company was founded by Ronald M. Evans and is headquartered in Sam Mateo, CA. | Miscellaneous Commercial Services | President Founder | |
| LIGAND PHARMACEUTICALS INCORPORATED | Pharmaceuticals: Major | Founder Chief Tech/Sci/R&D Officer | |
| Gensia Automedics, Inc. | President Corporate Officer/Principal | ||
Castle & Cooke, Inc.
 Castle & Cooke, Inc. HomebuildingConsumer Durables Castle & Cooke, Inc. owns and develops real estate, leases transportation equipment and manufactures brick. The firm conducts residential real estate development operations in Hawaii, Bakersfield, California, Sierra Vista, Arizona and Florida. The company was founded by Samuel Northrup Castle and Amos Starr Cooke on June 2, 1851 and is headquartered in Los Angeles, CA. | Homebuilding | Corporate Officer/Principal Corporate Officer/Principal | |
| CIDARA THERAPEUTICS, INC. | Pharmaceuticals: Other | Chairman Director/Board Member | |
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin | |
| ARBUTUS BIOPHARMA CORPORATION | Pharmaceuticals: Major | Director/Board Member Compliance Officer | |
| University of California, Berkeley | College/University | Graduate Degree Undergraduate Degree | |
| DNIB UNWIND INC | Biotechnology | Director/Board Member Director/Board Member | |
| Rutgers State University of New Jersey | College/University | Undergraduate Degree Masters Business Admin | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Director of Finance/CFO | |
| CADENCE PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Founder | |
Antimicrobials Working Group
 Antimicrobials Working Group Miscellaneous Commercial ServicesCommercial Services Antimicrobials Working Group is an American nonprofit company. The firm operates as an association of antimicrobials and diagnostics companies. The company says this about itself: AWG was founded in 2012 with the vision of utilizing collective power to improve the regulatory, investment, and commercial environment for emerging infectious disease companies. Today, AWG is comprised of thirteen antimicrobials companies: Acurx Pharmaceuticals, Inc., Cidara Therapeutics Inc., CorMedix Inc., Crestone, Inc., Entasis Therapeutics Inc., Iterum Therapeutics Ltd., Melinta Therapeutics LLC, Nabriva Therapeutics US Inc., Paratek Pharmaceuticals Inc., Qpex Biopharma, Inc., SCYNEXIS Inc., UTILITY therapeutics Ltd., and Venatorx Pharmaceuticals, Inc. | Miscellaneous Commercial Services | Chairman Chairman | |
| Louisiana State University | College/University | Undergraduate Degree Undergraduate Degree | |
| TREVENA, INC. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
TG Energy Industrial Services LLC
 TG Energy Industrial Services LLC Engineering & ConstructionIndustrial Services TG Energy Industrial Services LLC is an industrial services provider that offers civil, mechanical, electrical/instrumentation, and fabrication services. The company is based in Houston, TX. The company also provides professional services and staffing. The CEO of the company is Dave Maggio. | Engineering & Construction | Director/Board Member Chief Executive Officer | |
| SYNDAX PHARMACEUTICALS, INC. | Biotechnology | Founder Founder | |
| VIKING THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Amunix Pharmaceuticals, Inc.
 Amunix Pharmaceuticals, Inc. BiotechnologyHealth Technology Amunix Pharmaceuticals, Inc. manufactures and fabricates drugs. The firm’s pipeline products are based on proprietary XTEN half-life extension, Antibody-XTEN-Drug Conjugate, ProTIA pro-drug and bispecific T-cell engager platform technologies. The company was founded by Willem P.C. Stemmer and Volker Schellenberger in 2006 and is headquartered in Mountain View, CA. | Biotechnology | Chairman Director/Board Member | |
Mitobridge, Inc.
 Mitobridge, Inc. BiotechnologyHealth Technology Mitobridge, Inc. operates as a biopharmaceutical company. It focuses on the development and discovery of products for mitochondrial function. The firm also offers treatments for genetic, metabolic, and neurodegenerative disorders as well as diseases and conditions of aging. The company was founded by Kazumi Shiosaki, Andrew Dillin, Ronald M. Evans, Johan Auwerx and Robert H. Horvitz in October 2011 and is headquartered in Cambridge, MA. | Biotechnology | Founder | |
| NEUROCRINE BIOSCIENCES, INC. | Pharmaceuticals: Major | General Counsel | |
National Academy of Medicine (United States)
 National Academy of Medicine (United States) Miscellaneous Commercial ServicesCommercial Services The National Academy of Medicine (United States) is based in Washington and is focused on improving the health and well-being of individuals through various initiatives. These initiatives include the clinician well-being collaborative, which aims to accelerate the implementation of a national plan for health workforce well-being, and the development of a code of conduct for the use of artificial intelligence in health care. The organization also provides resources to support meaningful community engagement in health and health care programs and policies. Recently, the National Academy of Medicine announced the appointment of Mandy Cohen, a member of the organization, as the director of the Centers for Disease Control and Prevention. Additionally, the organization has released a publication celebrating 50 years of progress in biomedical science, health, and health care. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
National Academy of Sciences
 National Academy of Sciences Miscellaneous Commercial ServicesCommercial Services National Academy of Sciences operates as a private, nongovernmental institution that advises on issues related to science and technology. It provides independent, objective analysis and advice and conducts other activities to solve complex problems and inform public policy decisions. The firm also encourages education and research, recognize outstanding contributions to knowledge, and increase public understanding in matters of science. The company was founded on March 3, 1863 and is headquartered in Washington, DC. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Yumanity, Inc.
 Yumanity, Inc. Pharmaceuticals: MajorHealth Technology Yumanity, Inc. engages in transforming drug discovery for neurodegenerative diseases services. It provides integrated discovery platforms, phenotypic screening (uHTS) platforms, in which different protein misfolding pathologies are modeled in yeast to help discover compounds to correct these pathologies; a human neuronal platform. The company was founded by Anthony N. Coles, Jr. and Susan L. Lindquist in December 2014 and is headquartered in Boston, MA. | Pharmaceuticals: Major | Director/Board Member | |
American Academy of Arts & Sciences
 American Academy of Arts & Sciences Miscellaneous Commercial ServicesCommercial Services The American Academy of Arts & Sciences is an organization that honors excellence and brings together leaders. The non-profit company is based in Cambridge, MA. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Amunix, Inc.
 Amunix, Inc. Pharmaceuticals: MajorHealth Technology Amunix, Inc. develops protein pharmaceuticals. It offers XTEN which is hydrophilic, unstructured, biodegradable polypeptides that impart a number of favorable properties upon the molecules to which they are attached. The company was founded by Volker Schellenberger and Willem Stemmer in 2006 and is headquartered in Mountain View, CA. | Pharmaceuticals: Major | Director/Board Member | |
| University of California, Los Angeles | College/University | Undergraduate Degree | |
| Moores Cancer Center | Corporate Officer/Principal | ||
| ENLIVEN THERAPEUTICS, INC. | Biotechnology | Chairman | |
Synchronicity Pharma, Inc.
 Synchronicity Pharma, Inc. Pharmaceuticals: OtherHealth Technology Synchronicity Pharma, Inc. discovers, develops and commercializes novel therapeutics. Its products identify components of the circadian system that can be targeted to treat metabolic and related disorders, such as diabetes, obesity, and cardiovascular diseases. The company was founded by Ross S. Bersot, Joseph S. Takahashi, Masashi Yanagisawas and Ron Evans in 2008 and is headquartered in San Jose, CA. | Pharmaceuticals: Other | Founder | |
XTuit Pharmaceuticals, Inc.
 XTuit Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology XTuit Pharmaceuticals, Inc. develops drugs for the treatment of cancer. The firm develops pharmaceutical products for use in the diagnosis and treatment of oncological, tumor and inflammatory diseases. The company was founded by Alan L. Crane, Rakesh Kumar Jain, Andrew Werk Cook, Edwin L. Steele, David H. Koch, Ronald Evans, Howard Hughes and Robert S. Langer, Jr. in 2011 and is headquartered in Waltham, MA. | Pharmaceuticals: Major | Founder |
Statistik
International
| Vereinigte Staaten | 48 |
| Österreich | 2 |
| Vereinigtes Königreich | 2 |
| Belgien | 2 |
Sektoral
| Health Technology | 30 |
| Commercial Services | 10 |
| Consumer Services | 8 |
| Consumer Durables | 2 |
| Industrial Services | 2 |
Operativ
| Director/Board Member | 221 |
| Corporate Officer/Principal | 83 |
| Independent Dir/Board Member | 78 |
| Chief Executive Officer | 71 |
| President | 48 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Amir Nashat | 49 |
| Jay Lichter | 38 |
| Richard Heyman | 33 |
| Mark Corrigan | 29 |
| Daniel Burgess | 28 |
| Vickie Capps | 27 |
| Charles Rowland | 25 |
| Stephen Webster | 23 |
| James Breitmeyer | 16 |
| Theodore Schroeder | 16 |
| Jeffrey Jonker | 16 |
| Ciara Kennedy | 15 |
| John McHutchison | 14 |
| Ronald M. Evans | 14 |
| Andrew Guggenhime | 13 |
